HEMOSONICS

Basic Information

400 Preston Avenue
Suite 250
CHARLOTTESVILLE, VA, 22903-4585

http://www.hemosonics.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 193921041
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 6


  1. A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients

    Amount: $999,727.00

    HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management ...

    SBIR Phase II 2015 Department of DefenseDefense Health ProgramDepartment of Defense
  2. Assessment of Hypercoagulability in Cancer Patients Using Sonorheometry

    Amount: $202,931.00

    DESCRIPTION (provided by applicant): The Problem: Venous thromboembolism (VTE), which encompasses the diseases of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and life-threateni ...

    SBIR Phase I 2014 Department of Health and Human Services
  3. Development of a microfluidic device for the assessment of hemostatic function

    Amount: $224,845.00

    DESCRIPTION (provided by applicant): The monitoring and management of the hemostatic balance in neonatal and pediatric patients remains challenging. Although several conditions/procedures are known to ...

    SBIR Phase I 2014 Department of Health and Human Services
  4. A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients

    Amount: $149,968.00

    HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management ...

    SBIR Phase I 2014 Defense Health ProgramDepartment of DefenseDepartment of Defense
  5. Development of a point of care diagnostic to guide efficient usage of blood produ

    Amount: $2,241,062.00

    DESCRIPTION (provided by applicant): The Problem: Over 60% of the 600,000 patients undergoing cardio-pulmonary bypass (CPB) procedures in the US each year experience excessive bleeding, which requires ...

    SBIR Phase II 2013 Department of Health and Human Services
  6. Development of a diagnostic instrument to manage hemostasis in chronic liver dise

    Amount: $1,512,209.00

    DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two ...

    SBIR Phase II 2011 Department of Health and Human Services
  7. Development of a diagnostic instrument to manage hemostasis in chronic liver dise

    Amount: $317,884.00

    DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two ...

    SBIR Phase I 2010 Department of Health and Human Services
  8. Development of a point of care diagnostic to guide efficient usage of blood produ

    Amount: $298,626.00

    DESCRIPTION (provided by applicant): Over 60% of the 600,000 patients undergoing cardio-pulmonary bypass (CPB) procedures in the US each year experience intra- and post-operative bleeding. Treatment o ...

    SBIR Phase I 2010 Department of Health and Human Services
  9. Miniature, Portable, Device to Detect and Monitor Coagulopathy

    Amount: $69,992.00

    Trauma is a leading cause of both military and civilian mortality, accounting for roughly 10% of all deaths worldwide. Coagulopathy (disturbance of the physiologic balance between bleeding and clottin ...

    STTR Phase I 2010 NavyDepartment of DefenseDepartment of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government